Global Antiviral Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 89 pages | ID: GA1B0F3758FEEN
LP Information

Abstracts

According to this study, the global Antiviral Therapy market size will reach US$ million by 2031.

Antiviral therapy is one of the most exciting branches of virology. It entails several strategies used to develop antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive antibodies that neutralize viruses circulating in drug; and drugs that target cellular proteins or processes essential for viral replication.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Antiviral Therapy Industry Forecast” looks at past sales and reviews total world Antiviral Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Antiviral Therapy sales for 2025 through 2031. With Antiviral Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiviral Therapy industry.

This Insight Report provides a comprehensive analysis of the global Antiviral Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antiviral Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiviral Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiviral Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiviral Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Antiviral Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Generic Drugs
• Branded Drugs

Segmentation by Application:

• HIV
• Hepatitis
• Herpes
• Virus Influenza
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie Inc.
• Abbott
• F. Hoffmann-La Roche Ltd
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Aurobindo Pharma
• AstraZeneca

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antiviral Therapy Market Size (2020-2031)
  2.1.2 Antiviral Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Antiviral Therapy by Country/Region (2020, 2024 & 2031)
2.2 Antiviral Therapy Segment by Type
  2.2.1 Generic Drugs
  2.2.2 Branded Drugs
2.3 Antiviral Therapy Market Size by Type
  2.3.1 Antiviral Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Antiviral Therapy Market Size Market Share by Type (2020-2025)
2.4 Antiviral Therapy Segment by Application
  2.4.1 HIV
  2.4.2 Hepatitis
  2.4.3 Herpes
  2.4.4 Virus Influenza
  2.4.5 Others
2.5 Antiviral Therapy Market Size by Application
  2.5.1 Antiviral Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Antiviral Therapy Market Size Market Share by Application (2020-2025)

3 ANTIVIRAL THERAPY MARKET SIZE BY PLAYER

3.1 Antiviral Therapy Market Size Market Share by Player
  3.1.1 Global Antiviral Therapy Revenue by Player (2020-2025)
  3.1.2 Global Antiviral Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Antiviral Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTIVIRAL THERAPY BY REGION

4.1 Antiviral Therapy Market Size by Region (2020-2025)
4.2 Global Antiviral Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antiviral Therapy Market Size Growth (2020-2025)
4.4 APAC Antiviral Therapy Market Size Growth (2020-2025)
4.5 Europe Antiviral Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Antiviral Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Antiviral Therapy Market Size by Country (2020-2025)
5.2 Americas Antiviral Therapy Market Size by Type (2020-2025)
5.3 Americas Antiviral Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antiviral Therapy Market Size by Region (2020-2025)
6.2 APAC Antiviral Therapy Market Size by Type (2020-2025)
6.3 APAC Antiviral Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antiviral Therapy Market Size by Country (2020-2025)
7.2 Europe Antiviral Therapy Market Size by Type (2020-2025)
7.3 Europe Antiviral Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antiviral Therapy by Region (2020-2025)
8.2 Middle East & Africa Antiviral Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Antiviral Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTIVIRAL THERAPY MARKET FORECAST

10.1 Global Antiviral Therapy Forecast by Region (2026-2031)
  10.1.1 Global Antiviral Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Antiviral Therapy Forecast
  10.1.3 APAC Antiviral Therapy Forecast
  10.1.4 Europe Antiviral Therapy Forecast
  10.1.5 Middle East & Africa Antiviral Therapy Forecast
10.2 Americas Antiviral Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Antiviral Therapy Forecast
  10.2.2 Canada Market Antiviral Therapy Forecast
  10.2.3 Mexico Market Antiviral Therapy Forecast
  10.2.4 Brazil Market Antiviral Therapy Forecast
10.3 APAC Antiviral Therapy Forecast by Region (2026-2031)
  10.3.1 China Antiviral Therapy Market Forecast
  10.3.2 Japan Market Antiviral Therapy Forecast
  10.3.3 Korea Market Antiviral Therapy Forecast
  10.3.4 Southeast Asia Market Antiviral Therapy Forecast
  10.3.5 India Market Antiviral Therapy Forecast
  10.3.6 Australia Market Antiviral Therapy Forecast
10.4 Europe Antiviral Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Antiviral Therapy Forecast
  10.4.2 France Market Antiviral Therapy Forecast
  10.4.3 UK Market Antiviral Therapy Forecast
  10.4.4 Italy Market Antiviral Therapy Forecast
  10.4.5 Russia Market Antiviral Therapy Forecast
10.5 Middle East & Africa Antiviral Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Antiviral Therapy Forecast
  10.5.2 South Africa Market Antiviral Therapy Forecast
  10.5.3 Israel Market Antiviral Therapy Forecast
  10.5.4 Turkey Market Antiviral Therapy Forecast
10.6 Global Antiviral Therapy Forecast by Type (2026-2031)
10.7 Global Antiviral Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Antiviral Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie Inc.
  11.1.1 AbbVie Inc. Company Information
  11.1.2 AbbVie Inc. Antiviral Therapy Product Offered
  11.1.3 AbbVie Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AbbVie Inc. Main Business Overview
  11.1.5 AbbVie Inc. Latest Developments
11.2 Abbott
  11.2.1 Abbott Company Information
  11.2.2 Abbott Antiviral Therapy Product Offered
  11.2.3 Abbott Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Abbott Main Business Overview
  11.2.5 Abbott Latest Developments
11.3 F. Hoffmann-La Roche Ltd
  11.3.1 F. Hoffmann-La Roche Ltd Company Information
  11.3.2 F. Hoffmann-La Roche Ltd Antiviral Therapy Product Offered
  11.3.3 F. Hoffmann-La Roche Ltd Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 F. Hoffmann-La Roche Ltd Main Business Overview
  11.3.5 F. Hoffmann-La Roche Ltd Latest Developments
11.4 Bristol-Myers Squibb Company
  11.4.1 Bristol-Myers Squibb Company Company Information
  11.4.2 Bristol-Myers Squibb Company Antiviral Therapy Product Offered
  11.4.3 Bristol-Myers Squibb Company Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bristol-Myers Squibb Company Main Business Overview
  11.4.5 Bristol-Myers Squibb Company Latest Developments
11.5 Johnson & Johnson Services, Inc.
  11.5.1 Johnson & Johnson Services, Inc. Company Information
  11.5.2 Johnson & Johnson Services, Inc. Antiviral Therapy Product Offered
  11.5.3 Johnson & Johnson Services, Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Johnson & Johnson Services, Inc. Main Business Overview
  11.5.5 Johnson & Johnson Services, Inc. Latest Developments
11.6 Merck & Co., Inc.
  11.6.1 Merck & Co., Inc. Company Information
  11.6.2 Merck & Co., Inc. Antiviral Therapy Product Offered
  11.6.3 Merck & Co., Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Merck & Co., Inc. Main Business Overview
  11.6.5 Merck & Co., Inc. Latest Developments
11.7 Gilead Sciences, Inc.
  11.7.1 Gilead Sciences, Inc. Company Information
  11.7.2 Gilead Sciences, Inc. Antiviral Therapy Product Offered
  11.7.3 Gilead Sciences, Inc. Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Gilead Sciences, Inc. Main Business Overview
  11.7.5 Gilead Sciences, Inc. Latest Developments
11.8 GlaxoSmithKline plc
  11.8.1 GlaxoSmithKline plc Company Information
  11.8.2 GlaxoSmithKline plc Antiviral Therapy Product Offered
  11.8.3 GlaxoSmithKline plc Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 GlaxoSmithKline plc Main Business Overview
  11.8.5 GlaxoSmithKline plc Latest Developments
11.9 Aurobindo Pharma
  11.9.1 Aurobindo Pharma Company Information
  11.9.2 Aurobindo Pharma Antiviral Therapy Product Offered
  11.9.3 Aurobindo Pharma Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Aurobindo Pharma Main Business Overview
  11.9.5 Aurobindo Pharma Latest Developments
11.10 AstraZeneca
  11.10.1 AstraZeneca Company Information
  11.10.2 AstraZeneca Antiviral Therapy Product Offered
  11.10.3 AstraZeneca Antiviral Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 AstraZeneca Main Business Overview
  11.10.5 AstraZeneca Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antiviral Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Antiviral Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Generic Drugs
Table 4. Major Players of Branded Drugs
Table 5. Antiviral Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Antiviral Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Antiviral Therapy Market Size Market Share by Type (2020-2025)
Table 8. Antiviral Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Antiviral Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Antiviral Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Antiviral Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Antiviral Therapy Revenue Market Share by Player (2020-2025)
Table 13. Antiviral Therapy Key Players Head office and Products Offered
Table 14. Antiviral Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Antiviral Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Antiviral Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Antiviral Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Antiviral Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Antiviral Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Antiviral Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Antiviral Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Antiviral Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Antiviral Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Antiviral Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Antiviral Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Antiviral Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Antiviral Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Antiviral Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Antiviral Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Antiviral Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Antiviral Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Antiviral Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Antiviral Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Antiviral Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Antiviral Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Antiviral Therapy
Table 39. Key Market Challenges & Risks of Antiviral Therapy
Table 40. Key Industry Trends of Antiviral Therapy
Table 41. Global Antiviral Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Antiviral Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Antiviral Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Antiviral Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AbbVie Inc. Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 46. AbbVie Inc. Antiviral Therapy Product Offered
Table 47. AbbVie Inc. Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AbbVie Inc. Main Business
Table 49. AbbVie Inc. Latest Developments
Table 50. Abbott Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 51. Abbott Antiviral Therapy Product Offered
Table 52. Abbott Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Abbott Main Business
Table 54. Abbott Latest Developments
Table 55. F. Hoffmann-La Roche Ltd Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 56. F. Hoffmann-La Roche Ltd Antiviral Therapy Product Offered
Table 57. F. Hoffmann-La Roche Ltd Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. F. Hoffmann-La Roche Ltd Main Business
Table 59. F. Hoffmann-La Roche Ltd Latest Developments
Table 60. Bristol-Myers Squibb Company Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 61. Bristol-Myers Squibb Company Antiviral Therapy Product Offered
Table 62. Bristol-Myers Squibb Company Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Bristol-Myers Squibb Company Main Business
Table 64. Bristol-Myers Squibb Company Latest Developments
Table 65. Johnson & Johnson Services, Inc. Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 66. Johnson & Johnson Services, Inc. Antiviral Therapy Product Offered
Table 67. Johnson & Johnson Services, Inc. Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Johnson & Johnson Services, Inc. Main Business
Table 69. Johnson & Johnson Services, Inc. Latest Developments
Table 70. Merck & Co., Inc. Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 71. Merck & Co., Inc. Antiviral Therapy Product Offered
Table 72. Merck & Co., Inc. Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Merck & Co., Inc. Main Business
Table 74. Merck & Co., Inc. Latest Developments
Table 75. Gilead Sciences, Inc. Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 76. Gilead Sciences, Inc. Antiviral Therapy Product Offered
Table 77. Gilead Sciences, Inc. Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Gilead Sciences, Inc. Main Business
Table 79. Gilead Sciences, Inc. Latest Developments
Table 80. GlaxoSmithKline plc Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 81. GlaxoSmithKline plc Antiviral Therapy Product Offered
Table 82. GlaxoSmithKline plc Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. GlaxoSmithKline plc Main Business
Table 84. GlaxoSmithKline plc Latest Developments
Table 85. Aurobindo Pharma Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 86. Aurobindo Pharma Antiviral Therapy Product Offered
Table 87. Aurobindo Pharma Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Aurobindo Pharma Main Business
Table 89. Aurobindo Pharma Latest Developments
Table 90. AstraZeneca Details, Company Type, Antiviral Therapy Area Served and Its Competitors
Table 91. AstraZeneca Antiviral Therapy Product Offered
Table 92. AstraZeneca Antiviral Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AstraZeneca Main Business
Table 94. AstraZeneca Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Antiviral Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antiviral Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Antiviral Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Antiviral Therapy Sales Market Share by Country/Region (2024)
Figure 8. Antiviral Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Antiviral Therapy Market Size Market Share by Type in 2024
Figure 10. Antiviral Therapy in HIV
Figure 11. Global Antiviral Therapy Market: HIV (2020-2025) & ($ millions)
Figure 12. Antiviral Therapy in Hepatitis
Figure 13. Global Antiviral Therapy Market: Hepatitis (2020-2025) & ($ millions)
Figure 14. Antiviral Therapy in Herpes
Figure 15. Global Antiviral Therapy Market: Herpes (2020-2025) & ($ millions)
Figure 16. Antiviral Therapy in Virus Influenza
Figure 17. Global Antiviral Therapy Market: Virus Influenza (2020-2025) & ($ millions)
Figure 18. Antiviral Therapy in Others
Figure 19. Global Antiviral Therapy Market: Others (2020-2025) & ($ millions)
Figure 20. Global Antiviral Therapy Market Size Market Share by Application in 2024
Figure 21. Global Antiviral Therapy Revenue Market Share by Player in 2024
Figure 22. Global Antiviral Therapy Market Size Market Share by Region (2020-2025)
Figure 23. Americas Antiviral Therapy Market Size 2020-2025 ($ millions)
Figure 24. APAC Antiviral Therapy Market Size 2020-2025 ($ millions)
Figure 25. Europe Antiviral Therapy Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Antiviral Therapy Market Size 2020-2025 ($ millions)
Figure 27. Americas Antiviral Therapy Value Market Share by Country in 2024
Figure 28. United States Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Antiviral Therapy Market Size Market Share by Region in 2024
Figure 33. APAC Antiviral Therapy Market Size Market Share by Type (2020-2025)
Figure 34. APAC Antiviral Therapy Market Size Market Share by Application (2020-2025)
Figure 35. China Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. India Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Antiviral Therapy Market Size Market Share by Country in 2024
Figure 42. Europe Antiviral Therapy Market Size Market Share by Type (2020-2025)
Figure 43. Europe Antiviral Therapy Market Size Market Share by Application (2020-2025)
Figure 44. Germany Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. France Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Antiviral Therapy Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Antiviral Therapy Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Antiviral Therapy Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Antiviral Therapy Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 58. APAC Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 59. Europe Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 61. United States Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 62. Canada Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 63. Mexico Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 64. Brazil Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 65. China Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 66. Japan Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 67. Korea Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 69. India Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 70. Australia Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 71. Germany Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 72. France Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 73. UK Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 74. Italy Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 75. Russia Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 76. Egypt Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 77. South Africa Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 78. Israel Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 79. Turkey Antiviral Therapy Market Size 2026-2031 ($ millions)
Figure 80. Global Antiviral Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Antiviral Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Antiviral Therapy Market Size 2026-2031 ($ millions)